-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, BSlKbjYp/CLWqn95JsuDApOCP/3Ur4lyKOXBQjD4d3iIP1bs9ALRu2OGhNT/a1qu YTMbDPEJh1R1Gf03IyWKfQ== 0001181431-05-024071.txt : 20050428 0001181431-05-024071.hdr.sgml : 20050428 20050428144729 ACCESSION NUMBER: 0001181431-05-024071 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20041201 FILED AS OF DATE: 20050428 DATE AS OF CHANGE: 20050428 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PATOU GARY CENTRAL INDEX KEY: 0001283535 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-10824 FILM NUMBER: 05780040 BUSINESS ADDRESS: STREET 1: 100 BEAVER ST CITY: WALTHAM STATE: MA ZIP: 02453 BUSINESS PHONE: 6508371850 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OSCIENT PHARMACEUTICALS CORP CENTRAL INDEX KEY: 0000356830 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 042297484 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1000 WINTER STREET STREET 2: SUITE 2200 CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 7813982300 MAIL ADDRESS: STREET 1: 1000 WINTER STREET STREET 2: SUITE 2200 CITY: WALTHAM STATE: MA ZIP: 02451 FORMER COMPANY: FORMER CONFORMED NAME: GENOME THERAPEUTICS CORP DATE OF NAME CHANGE: 19941215 FORMER COMPANY: FORMER CONFORMED NAME: COLLABORATIVE RESEARCH INC DATE OF NAME CHANGE: 19920703 4/A 1 rrd76980.xml X0202 4/A 2004-12-01 2004-12-03 0 0000356830 OSCIENT PHARMACEUTICALS CORP OSCI 0001283535 PATOU GARY 1000 WINTER ST. WALTHAM MA 02451 1 0 0 0 Common Stock 2004-12-03 4 M 0 102511 1.18 A 144451 D Common Stock 2004-12-03 4 S 0 74500 3.57 D 69951 D Employee Stock Option (right to buy) .07 2004-12-01 4 M 0 122373 0 D 2004-01-01 2013-02-10 Common Stock 122373 518122 D Transaction occurred in accordance with the terms and conditions of a Rule 10b5-1 Trading Plan This Form 4/A makes a correction in the number of shares sold - previous reported was 80,000 on 12/3/04, should have been 74,500 Robert E. Farrell, Jr. Corp Controller - power of attorney 2005-04-28 -----END PRIVACY-ENHANCED MESSAGE-----